Location History:
- Grobenzell, DE (2004 - 2005)
- Neuried, DE (2007 - 2008)
Company Filing History:
Years Active: 2004-2008
Title: Christine Meisinger: Innovator in Vaccinology
Introduction
Christine Meisinger, an accomplished inventor based in Neuried, Germany, has made significant contributions to the field of vaccinology. With four patents to her name, she has focused her research on enhancing vaccine effectiveness and safety, particularly in immunocompromised individuals.
Latest Patents
Among her latest inventions is the "Modified Vaccinia Ankara virus variant and cultivation method". This patent describes an attenuated virus derived from the Modified Vaccinia Ankara virus, which loses its ability to replicate in human cell lines. The innovation not only details recombinant viruses derived from this attenuated strain but also presents methods for administering them as medicaments or vaccines. Importantly, her work provides strategies for inducing immune responses in individuals who may be immunocompromised or receiving antiviral therapy, ensuring broader access to effective vaccination. Additionally, it includes a novel method for virus amplification in primary cells cultivated in serum-free medium, promoting the production of viruses devoid of infectious agents typically found in animal sera.
Career Highlights
Christine Meisinger is associated with Bavarian Nordic A/S, a global leader in developing and manufacturing innovative vaccines. Her work at the company reflects her commitment to advancing medical science through her research and intellectual property.
Collaborations
Collaborating with notable professionals in her field, Christine works alongside colleagues such as Paul Chaplin and Paul Michael Howley. Their combined expertise enhances the innovative efforts within the company, driving forward the research and development of novel vaccines.
Conclusion
Christine Meisinger represents a pioneering force in the development of vaccines tailored for specific populations. Her commitment to improving public health through innovative solutions stands as a testament to her capabilities as an inventor and researcher. With her latest patents, she continues to contribute to the vital intersection of medical research and practical application, ensuring safer and more effective vaccines for those in need.